Form 4: Cytokinetics EVP Fady Ibraham Malik Reports Gift of Common Stock
SEC Form 4 Filing
Fady Ibraham Malik, EVP of Research & Development at Cytokinetics, reported a gift of 150 shares of common stock on April 12, 2024.
Summary
- On April 15, 2024, a Form 4 filing was submitted to the SEC regarding Fady Ibraham Malik, EVP of Research & Development at Cytokinetics Inc.
- The filing reports a transaction that occurred on April 12, 2024, where Malik gifted 150 shares of Cytokinetics common stock.
- Following the transaction, Malik directly owns 138,417 shares of Cytokinetics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding a stock gift, which is neither inherently positive nor negative.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 04/12/2024 | Date of the stock gift transaction |
| 04/15/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.